GeoVax Labs, Inc. (GOVX) income statement
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.99−0.02 (-1.00%)
Close on Nov 18, 2026Market cap $14.66MP/E –Yield –
GeoVax Labs, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -483.8%
Financial strength
- Current ratio
- 1.54
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 115.9%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 8.33
- Dividend yield
- –
See a number that looks wrong?